Page last updated: 2024-09-03

rasagiline and Alloxan Diabetes

rasagiline has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abassi, Z; Abu-Saleh, N; Armaly, Z; Awad, H; Heyman, SN; Holman, J; Ichimura, T; Kaballa, A; Karram, T; Khamaisi, M	1

Other Studies

1 other study(ies) available for rasagiline and Alloxan Diabetes

Article	Year
Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury. American journal of physiology. Renal physiology, 2014, Jan-01, Volume: 306, Issue:1 Topics: Acute Kidney Injury; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Indans; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spin Labels; Stress, Physiological	2014

Article

Year

Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury.

American journal of physiology. Renal physiology, 2014, Jan-01, Volume: 306, Issue:1

Topics: Acute Kidney Injury; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Indans; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spin Labels; Stress, Physiological

2014